53 related articles for article (PubMed ID: 34348602)
1. Profiles of Radioresistance Mechanisms in Prostate Cancer.
Chaiswing L; Weiss HL; Jayswal RD; Clair DKS; Kyprianou N
Crit Rev Oncog; 2018; 23(1-2):39-67. PubMed ID: 29953367
[TBL] [Abstract][Full Text] [Related]
2. Emergence of miR-34a in radiation therapy.
Lacombe J; Zenhausern F
Crit Rev Oncol Hematol; 2017 Jan; 109():69-78. PubMed ID: 28010900
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy Metastatic Prostate Cancer Cell Lines Treated with Gold Nanorods Modulate miRNA Signatures.
Soares S; Aires F; Monteiro A; Pinto G; Faria I; Sales G; Correa-Duarte MA; Guerreiro S; Fernandes R
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474003
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA in radiotherapy: miRage or miRador?
Korpela E; Vesprini D; Liu SK
Br J Cancer; 2015 Mar; 112(5):777-82. PubMed ID: 25611301
[TBL] [Abstract][Full Text] [Related]
5. Molecularly targeted radiosensitization chances towards gene aberration-due organ confined/regionally advanced prostate cancer radioresistance.
Alberti C
G Chir; 2015; 36(3):133-6. PubMed ID: 26188759
[TBL] [Abstract][Full Text] [Related]
6. miRNAs in radiotherapy resistance of cancer; a comprehensive review.
Al-Hawary SIS; Abdalkareem Jasim S; Altalbawy FMA; Kumar A; Kaur H; Pramanik A; Jawad MA; Alsaad SB; Mohmmed KH; Zwamel AH
Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38805114
[TBL] [Abstract][Full Text] [Related]
7. A Novel Approach for Position Verification and Dose Calculation through Local MVCT Reconstruction.
Zhang J; Chen Z; Lei Y; Wen J
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472954
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-146a-A Key Player in Immunity and Diseases.
Gilyazova I; Asadullina D; Kagirova E; Sikka R; Mustafin A; Ivanova E; Bakhtiyarova K; Gilyazova G; Gupta S; Khusnutdinova E; Gupta H; Pavlov V
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628949
[TBL] [Abstract][Full Text] [Related]
9. Association between microRNAs 10b/21/34a and acute toxicity in glioblastoma patients treated with radiotherapy and temozolomide.
Stepanović A; Nikitović M; Stanojković TP; Grujičić D; Bukumirić Z; Srbljak I; Ilić R; Milošević S; Arsenijević T; Petrović N
Sci Rep; 2022 May; 12(1):7505. PubMed ID: 35525840
[TBL] [Abstract][Full Text] [Related]
10. Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
Mireștean CC; Iancu RI; Iancu DPT
Curr Oncol; 2022 Feb; 29(2):816-833. PubMed ID: 35200568
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-107 enhances radiosensitivity by suppressing granulin in PC-3 prostate cancer cells.
Lo HC; Hsu JH; Lai LC; Tsai MH; Chuang EY
Sci Rep; 2020 Sep; 10(1):14584. PubMed ID: 32883962
[TBL] [Abstract][Full Text] [Related]
12. Association between miR-21/146a/155 level changes and acute genitourinary radiotoxicity in prostate cancer patients: A pilot study.
Kopcalic K; Petrovic N; Stanojkovic TP; Stankovic V; Bukumiric Z; Roganovic J; Malisic E; Nikitovic M
Pathol Res Pract; 2019 Apr; 215(4):626-631. PubMed ID: 30554863
[TBL] [Abstract][Full Text] [Related]
13. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in Prostate Cancer Following Radiotherapy: Towards Predicting Response to Radiation Treatment.
Petrović N; Stanojković TP; Nikitović M
Curr Med Chem; 2022; 29(9):1543-1560. PubMed ID: 34348602
[TBL] [Abstract][Full Text] [Related]
15. miRNAs and radiotherapy response in prostate cancer.
Konoshenko MY; Bryzgunova OE; Laktionov PP
Andrology; 2021 Mar; 9(2):529-545. PubMed ID: 33053272
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
